NCT03965741View on ClinicalTrials.gov

Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners

CompletedOBSERVATIONAL
Enrollment

97,765

Participants

Timeline

Start Date

May 30, 2019

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Venous Thromboembolism (VTE)
Interventions
DRUG

Rivaroxaban (Xarelto, BAY59-7939)

Follow clinical administration

DRUG

Apixaban(Eliquis)

Follow clinical administration

DRUG

Pradaxa (Dabigatran etexilate)

Follow clinical administration

Trial Locations (1)

Unknown

Many Locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
collaborator

Janssen Research & Development, LLC

INDUSTRY

lead

Bayer

INDUSTRY